首页> 外文期刊>The international journal of artificial organs >Management of fluid balance in continuous renal replacement therapy: Technical evaluation in the pediatric setting.
【24h】

Management of fluid balance in continuous renal replacement therapy: Technical evaluation in the pediatric setting.

机译:连续性肾脏替代治疗中液体平衡的管理:儿科环境中的技术评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Fluid overload control and fluid balance management represent very important factors in critically ill children requiring renal replacement therapy. A relatively high fluid volume administration in children and neonates is often necessary to deliver adequate amounts of blood derivatives, vasopressors, antibiotics, and parenteral nutrition. Fluid balance errors during pediatric continuous renal replacement therapy (CRRT) might significantly impact therapy delivery and have been described as potentially lethal. The aim of this study was to evaluate the accuracy of delivered vs. prescribed net ultrafiltration (UF) during CRRT applied to 2 neonates and 2 small children, either as dialytic treatment alone or during extracorporeal membrane oxygenation (ECMO). In accordance with an Acute Dialysis Quality Initiative workgroup statement, net UF was defined as the ""overall amount of fluid extracted from the patient in a given time"". Mean prescribed net UF was 18.5 ml/h (SD=6.7) during neonatal treatments and 70.3 ml/h (SD=22.5) during CRRT in small children. Daily net UF ranged from 200 mL to about 600 mL in the 2 neonates and from 1,200 to 1800 mL in the 2 children. The percentage error of delivered net UF ranged from -1.6% to 5.8% of the prescribed level. The mean error of the ECMO/CRRT patients was 3.024 ml/h vs. 0.45 m/h for the CRRT patients (p<0.001). The same difference was not evident when the 2 neonates were compared with the 2 small children (without considering the presence of ECMO). CRRT and net UF delivery appeared to be accurate, safe, and effective in this small cohort of high-risk pediatric patients.
机译:液体超负荷控制和液体平衡管理是需要肾脏替代疗法的重症儿童的重要因素。为了提供足够量的血液衍生物,升压药,抗生素和肠胃外营养,通常需要在儿童和新生儿中使用相对较高的液体量。小儿连续性肾脏替代治疗(CRRT)期间的液体平衡错误可能会严重影响治疗的实施,并已被描述为可能致命。这项研究的目的是评估CRRT应用于单独的透析治疗或体外膜氧合(ECMO)期间对2例新生儿和2个小孩进行CRRT时相对于规定的净超滤(UF)的准确性。根据急性透析质量倡议工作组的声明,净UF定义为““在给定时间内从患者体内提取的液体总量””。新生儿治疗期间的平均处方净UF为18.5 ml / h(SD = 6.7),CRRT治疗期间为70.3 ml / h(SD = 22.5)。 2名新生儿的每日净UF在200 mL至约600 mL的范围内,而2名儿童在1200至1800 mL的范围内。交付的净超滤的百分比误差在规定水平的-1.6%至5.8%之间。 ECMO / CRRT患者的平均误差为3.024 ml / h,而CRRT患者为0.45 m / h(p <0.001)。将2名新生儿与2名幼儿进行比较时,没有发现相同的差异(不考虑ECMO的存在)。在这个小规模的高危儿科患者队列中,CRRT和超滤净递送似乎是准确,安全和有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号